These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1329330)

  • 1. Expression of Epstein-Barr virus membrane antigen gp350/220 in E. coli and in insect cells.
    Nuebling CM; Buck M; Boos H; von Deimling A; Mueller-Lantzsch N
    Virology; 1992 Nov; 191(1):443-7. PubMed ID: 1329330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformation-dependent recognition of baculovirus-expressed Epstein-Barr virus gp350 by a panel of monoclonal antibodies.
    Zhang PF; Marcus-Sekura CJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2171-9. PubMed ID: 7691988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.
    Whang Y; Silberklang M; Morgan A; Munshi S; Lenny AB; Ellis RW; Kieff E
    J Virol; 1987 Jun; 61(6):1796-807. PubMed ID: 3033311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the epitopes of Epstein-Barr virus gp350 using monoclonal antibodies and recombinant proteins expressed in Escherichia coli defines three antigenic determinants.
    Zhang PF; Klutch M; Armstrong G; Qualtiere L; Pearson G; Marcus-Sekura CJ
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2747-55. PubMed ID: 1719128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the Epstein-Barr virus latent membrane protein (LMP) in insect cells and detection of antibodies in human sera against this protein.
    Chen HF; Kevan-Jah S; Suentzenich KO; Grässer FA; Mueller-Lantzsch N
    Virology; 1992 Sep; 190(1):106-15. PubMed ID: 1326801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the critical attribute(s) of EBV gp350 antigen required for elicitation of a neutralizing antibody response in vivo.
    Servat E; Ro BW; Cayatte C; Gemmell L; Barton C; Rao E; Lin R; Zuo F; Woo JC; Hayes GM
    Vaccine; 2015 Nov; 33(48):6771-7. PubMed ID: 26485517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity.
    Khyatti M; Patel PC; Stefanescu I; Menezes J
    J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of Epstein-Barr virus gp350-expressing transfected human lymphoid (Raji) cell clones.
    Khyatti M; Patel PC; Menezes J
    Int J Cancer; 1991 Jun; 48(4):591-7. PubMed ID: 1646179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets.
    Khyatti M; Stefanescu I; Blagdon M; Menezes J
    J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigenic analysis of the Epstein-Barr virus major membrane antigen (gp350/220) expressed in yeast and mammalian cells: implications for the development of a subunit vaccine.
    Emini EA; Schleif WA; Armstrong ME; Silberklang M; Schultz LD; Lehman D; Maigetter RZ; Qualtiere LF; Pearson GR; Ellis RW
    Virology; 1988 Oct; 166(2):387-93. PubMed ID: 2845652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220.
    Sairenji T; Bertoni G; Medveczky MM; Medveczky PG; Nguyen QV; Humphreys RE
    J Virol; 1988 Aug; 62(8):2614-21. PubMed ID: 2839689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High Epstein-Barr Virus Load and Genomic Diversity Are Associated with Generation of gp350-Specific Neutralizing Antibodies following Acute Infectious Mononucleosis.
    Weiss ER; Alter G; Ogembo JG; Henderson JL; Tabak B; Bakiş Y; Somasundaran M; Garber M; Selin L; Luzuriaga K
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27733645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Epstein-Barr virus nuclear antigen 2 in insect cells from a baculovirus vector.
    Schubach WH; Horvath G; Spoth B; Hearing JC
    Virology; 1991 Nov; 185(1):428-31. PubMed ID: 1656595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene mapping and expression of two immunodominant Epstein-Barr virus capsid proteins.
    van Grunsven WM; van Heerde EC; de Haard HJ; Spaan WJ; Middeldorp JM
    J Virol; 1993 Jul; 67(7):3908-16. PubMed ID: 7685403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two major outer envelope glycoproteins of Epstein-Barr virus are encoded by the same gene.
    Beisel C; Tanner J; Matsuo T; Thorley-Lawson D; Kezdy F; Kieff E
    J Virol; 1985 Jun; 54(3):665-74. PubMed ID: 2987520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope mapping of the major Epstein-Barr virus outer envelope glycoprotein gp350/220.
    Qualtiere LF; Decoteau JF; Hassan Nasr-el-Din M
    J Gen Virol; 1987 Feb; 68 ( Pt 2)():535-43. PubMed ID: 2434608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of VCA (viral capsid antigen) and EBNA1 (Epstein-Barr-virus-encoded nuclear antigen 1) genes of Epstein-Barr virus in Pichia pastoris and application of the products in a screening test for patients with nasopharyngeal carcinoma.
    Hu B; Hong G; Li Z; Xu J; Zhu Z; Li L
    Biotechnol Appl Biochem; 2007 May; 47(Pt 1):59-69. PubMed ID: 17129209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular synthesis of Epstein-Barr virus membrane antigen gp350/220. Inhibitory effect of monensin on its expression.
    Bertoni G; Nguyen QV; Humphreys RE; Sairenji T
    Intervirology; 1989; 30(2):61-73. PubMed ID: 2542183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen.
    Jung S; Chung YK; Chang SH; Kim J; Kim HR; Jang HS; Lee JC; Chung GH; Jang YS
    Mol Cells; 2001 Aug; 12(1):41-9. PubMed ID: 11561729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular profile of a human monoclonal antibody Fab fragment specific for Epstein-Barr virus gp350/220 antigen.
    Bugli F; Bastidas R; Burton DR; Williamson RA; Clementi M; Burioni R
    Hum Immunol; 2001 Apr; 62(4):362-7. PubMed ID: 11295468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.